Izzy Englander Buys Obesity Drug Stock

This is a LLY news story, published by Yahoo Finance, that relates primarily to Izzy Englander news.

LLY news

For more LLY news, you can click here:

more LLY news

Izzy Englander news

For more Izzy Englander news, you can click here:

more Izzy Englander news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Obesity Drug Stock

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pharma stock news, Lilly shares news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

big pharma stock

The Motley Fool

•

Billionaire Izzy Englander recently bought an obesity drug stock that could soar nearly 20% over the next 12 months

Summary

Nutrition label

66% Informative

Billionaire Izzy Englander recently bought an obesity drug stock that could soar nearly 20% over the next 12 months , according to Wall Street.

Englander loaded up on Eli Lilly ( NYSE : LLY ) stock in Q3 , increasing its stake by 86% .

The average 12-month price target for Lilly reflects an upside potential of 19% , even though the stock has soared more than 40% this year .

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month . The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002

Stock Advisor returns as of December 2, 2024 Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20% , According to Wall Street was originally published by The Motley Fool .

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful